Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics (UTHR) is a Top-Ranked Value Stock: Should You Buy?
10:45am, Monday, 04'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
United Therapeutics Q3 Earnings & Sales Beat Estimates
11:20am, Friday, 01'st Nov 2024
UTHR reports better-than-expected results in third-quarter 2024 on the back of strong demand for its treprostinil medications, especially Tyvaso.
United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript
03:09pm, Wednesday, 30'th Oct 2024
United Therapeutics Corporation (NASDAQ:UTHR ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairpe
Here's What Key Metrics Tell Us About United Therapeutics (UTHR) Q3 Earnings
10:35am, Wednesday, 30'th Oct 2024
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare w
United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
08:41am, Wednesday, 30'th Oct 2024
United Therapeutics (UTHR) came out with quarterly earnings of $6.39 per share, beating the Zacks Consensus Estimate of $6.18 per share. This compares to earnings of $5.38 per share a year ago.
United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
06:30am, Wednesday, 30'th Oct 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter
Curious about United Therapeutics (UTHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Tuesday, 29'th Oct 2024
Beyond analysts' top -and-bottom-line estimates for United Therapeutics (UTHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for
United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
06:30am, Wednesday, 23'rd Oct 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its third quarter 2024 financial results before
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
07:00am, Tuesday, 24'th Sep 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five presentations and one poster
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 30'th Aug 2024
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock?
United Therapeutics Shares Thrive
12:02pm, Friday, 30'th Aug 2024
Revenue growth and a recent regulatory win are driving shares of United Therapeutics Corporation (UTHR) upward.
United Therapeutics: Economics Support Compounding Ability
10:00pm, Monday, 19'th Aug 2024
United Therapeutics Corporation remains a buy with strong growth potential and high returns on invested capital. Q2 FY'24 earnings show continued growth in sales and earnings, with upsides in its Tyva
Stock Market Fades Badly As Dow Jones Index Turns Back At This Critical Level
05:41pm, Wednesday, 07'th Aug 2024
The stock market's bearish reversal left its rebound in doubt but a rally attempt remains in play.
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
01:33pm, Sunday, 04'th Aug 2024
The biotech industry, often recognized for its rapid innovation, can set investors up for outsized returns in the stock market. However, not all biotech companies have the capability of doing so.
United Therapeutics (UTHR) is a Great Momentum Stock: Should You Buy?
01:01pm, Friday, 02'nd Aug 2024
Does United Therapeutics (UTHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
